Home > Market > Market Stats >  Dr Reddys Laboratories

Company Summary

DR REDDYS LABORATORIES SUMMARY

Dr Reddys Laboratories is trading 1.68% upper at Rs 4423.10 as compared to its last closing price. Dr Reddys Laboratories has been trading in the price range of 4468.75 & 4332.05. Dr Reddys Laboratories has given 2.64% in this year & 0.48% in the last 5 days.

 

Dr Reddys Laboratories has TTM P/E ratio 19.3 as compared to the sector P/E of 30.05. There are 40 analysts who have initiated coverage on Dr Reddys Laboratories. There are 14 analysts who have given it a strong buy rating & 17 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.

 

The company posted a net profit of 1243.9 Crores in its last quarter.

 

Listed peers of Dr Reddys Laboratories include Cipla (-0.16%), Divis Laboratories (-0.28%), Dr Reddys Laboratories (1.68%) etc.

 

Dr Reddys Laboratories has a 26.7% promoter holding & 0.25% public holding.

FAQs about Dr Reddys Laboratories

Dr Reddys Laboratories is trading at 4423.10 as on 7 Feb, 2023 10:25:39 AM. This is 1.68% upper as compared to its previous closing price of 4350.05
The market capitalization of Dr Reddys Laboratories is 72246.41 Cr as on 7 Feb, 2023 10:25:39 AM.
The average broker rating on Dr Reddys Laboratories is Buy. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 2 analysts have given a sell rating
  • 6 analysts have given a hold rating
  • 17 analysts have given a buy rating
  • 14 analysts have given a strong buy rating
The 52 wk high for Dr Reddys Laboratories is 4645.55 whereas the 52 wk low is 3655.0
Dr Reddys Laboratories can be analyzed on the following key metrics -
  • TTM P/E: 19.3
  • Sector P/E: 30.05
  • Dividend Yield: 0.69%
  • D/E ratio: -
Dr Reddys Laboratories reported a net profit of 2182.5 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout